Hip Reconstruction Devices Market is predicted to reach USD 13.78 billion at a CAGR of 7.00% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Hip Reconstruction Devices Market”.

The Hip Reconstruction Devices Market is estimated to register a CAGR of 7.00% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global Hip Reconstruction Devices Market— Zimmer Biomet, Johnson & Johnson, Stryker, Smith & Nephew, B. Braun Melsungen AG, Waldemar Link GmbH & Co. KG, Surgival, Exactech, Inc., LimaCorporate S.p.a., Microport, Hip Innovation Technology LLC, and JointMedica.

Market Highlights

The global Hip Reconstruction Devices Market is accounted to register a CAGR of 7.00% during the forecast period and is estimated to reach USD 13.78 billion by 2032.

The rising incidence of osteoarthritis (OA) and rheumatoid arthritis (RA), coupled with a growing volume of trauma cases, is fueling heightened global demand for hip replacement implants.

Access full report @ https://www.marketresearchfuture.com/reports/hip-reconstruction-devices-market-16087

Segment Analysis

The global Hip Reconstruction Devices Market has been segmented based on the Product Type and End-User.

Based on the Product Type, the market is segmented into Primary Hip Reconstruction Devices, Partial Hip Reconstruction Devices, Hip Resurfacing Devices, and others. The Hip resurfacing devices segment was attributed to holding the largest market share in 2022.  A hip resurfacing device is a metallic prosthesis implant utilized in hip resurfacing surgery to address specific bones in the hip region. This implant effectively manages pain and serves as a replacement for damaged bone and tissues, including cartilage, enhancing overall joint mobility. The utilization of hip resurfacing devices is on the rise for addressing hip pain and related issues. Numerous studies have underscored the efficacy, safety, and enduring benefits of hip resurfacing surgery. For instance, a study featured in the Canadian Journal of Surgery in May 2022 emphasized the positive functional outcomes of the Birmingham hip resurfacing (BHR) for treating osteoarthritis. The study further highlighted that the BHR demonstrated more than a decade of durable performance in male patients. Notably, female patients who underwent Birmingham hip resurfacing surgery exhibited comparable Harris Hip Scores (HHS) and visual analog scale (VAS) outcomes to their male counterparts undergoing the same procedure.

Based on the End-User, the Hip Reconstruction Devices Market has been segmented into Hospitals, Orthopedic Clinics, and Others. The orthopedic clinics segment was expected to hold the largest market share in 2022. The increasing trend of outpatient procedures and the proliferation of specialized orthopedic clinics contribute significantly to this growth. These clinics offer personalized and cost-effective services for individuals requiring hip reconstruction procedures.

Regional Analysis

The global Hip Reconstruction Devices Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Hip Reconstruction Devices Market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Hip Reconstruction Devices Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Hip Reconstruction Devices Market comprises of Middle East, Africa, and Latin America.

The largest market share for the Hip Reconstruction Devices Market was maintained by the North American regional sector. Anticipated significant growth in North America during the forecast period is attributed to factors such as the region's advanced healthcare infrastructure, a notable burden of hip fractures and hip osteoarthritis, and the presence of key industry players. The region particularly experiences a high incidence of hip fracture cases, especially among the elderly population. For instance, according to data from the American Joint Replacement Registry Annual Report 2022, the United States saw over 2.6 million cases of hip and knee arthroplasty procedures in 2021, with primary hip procedures accounting for 37.3% of the total cases. Similarly, the Canadian Institute for Health Information (CIHI) reported over 55,300 hip replacements in Canada during the 2020-21 period.

Moreover, the Europe market has been persistently growing over the forecast period.  The region has experienced a high prevalence of osteoporosis and osteoarthritis among the elderly population, which are the primary indications for Total Hip Replacement (THR). The incidence of hip fractures increases significantly with advancing age, attributed to the degeneration and weakening of the hip joint, including the femoral head and acetabulum socket. Other indications for THR include osteonecrosis, infections, and dysplasia. According to The National Osteoporosis Society, in the UK alone, approximately 13,800 deaths occur annually due to hip fractures, and it is projected that by 2016, the country will witness around 117,000 hip fractures each year.

This trend is attributed to the increasing prevalence of osteoporosis resulting in hip fractures in the Asia-Pacific region. As per data from the International Osteoporosis Foundation in 2021, over 50% of all osteoporotic hip fractures are projected to occur in Asia by the year 2050. Furthermore, the improvement in healthcare infrastructure, the rise in per capita healthcare expenditure, increasing disposable income, elevated rates of obesity among the Asian population, and a growing elderly population experiencing rising musculoskeletal disorders will contribute to the demand for hip reconstruction and replacement devices in the region

The Asia-Pacific region is undergoing significant urbanization, marked by a substantial concentration of the population in densely populated urban areas. This urbanization trend stands as a prominent and transformative force in the business landscape of the region. More than 2.2 billion people, constituting 54% of the global urban population, reside in Asia. Projections indicate a further surge, with the urban population expected to grow by 50%—an additional 1.2 billion people—by 2050. This demographic shift underscores a burgeoning demand for innovative and sustainable public transportation solutions. In the face of expanding cities and heightened population density, the business landscape is witnessing an escalating need for transportation options that are not only efficient but also aligned with sustainability objectives. Hip Reconstruction devices, with their capacity to elevate mobility within urban environments, present a strategic alignment with the evolving demands of rapidly growing cities.

Furthermore, the rest of the world's Hip Reconstruction Devices Market is divided into the Middle East, Africa, and Latin America. The industry's growth in this region is further propelled by various government initiatives aimed at enhancing healthcare infrastructure and widening access to medical services. Additionally, the demand for hip reconstruction devices in the region is spurred by the growing incidence of hip fractures and a surge in the adoption of minimally invasive surgical procedures.

Key Findings of the Study

• The global Hip Reconstruction Devices Market is expected to reach USD 13.78 billion by 2032, at a CAGR of 7.00% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the growing awareness among the key stakeholders, rise in per capita income, availability of large medical unmet needs, increase in the prevalence of orthopedic diseases, etc.


• Based on Product Type, the Hip Resurfacing Devices segment was attributed to holding the largest market in 2022, with an approximate market share of 55–60%.


• Zimmer Biomet, Johnson & Johnson, Stryker, Smith & Nephew, B. Braun Melsungen AG, Waldemar Link GmbH & Co. KG, Surgival, Exactech, Inc., LimaCorporate S.p.a., Microport, Hip Innovation Technology LLC, and JointMedica